<DOC>
	<DOC>NCT01044472</DOC>
	<brief_summary>The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.</brief_summary>
	<brief_title>Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead</brief_title>
	<detailed_description>To evaluate the hemodynamic impact of different pacing MSLV configurations.</detailed_description>
	<criteria>Patients who have a recognised indication to receive a CRTD device or an upgrade from a pacemaker or ICD to a CRTD system. Patients have signed an informed consent form indicating their willingness to participate to this study. Patients who are unable to comply with the followup schedule based on their geographic location or for any reason. Patients with second or third degree AV Block Patients with intrinsic atrial rhythm &lt; 40 bpm Patients with a previously implanted left ventricular pacing lead. Patients who are pregnant. Patients currently participating in a clinical investigation that includes an active treatment arm. Patients under 18 years of age. Patients with a life expectancy of less then 6 months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>CRT-D</keyword>
</DOC>